<p><b>A</b>. Representative micrograph images of cells from the telomerase-positive cell line HeLa and three ALT cell lines, VA-13, Saos-2 and U-2 OS. Cells were fixed and immunofluorescently labeled with antibodies to BRCA1 (red) and WRN (green), and the nucleus is stained with DAPI (blue). <b>B</b>. A graphical representation of at least three independent experiments averaged to yield the percentage of each cell type with co-localized BRCA1-WRN foci.</p
<p>SK-N-MC cells were exposed to cisplatinum or doxorubicin for 1 hour and then resuspended in drug ...
<p>(<b>A</b>) Immunostaining-FISH images of WT.1 cells showing co-localization between telomerase RN...
<p>(A) Graph evidence the relative TRT activity of DPSCs cultured in 1.25% HS medium, 10% FBS and 1....
<p>U2OS cells were synchronized and stained with antibodies to BRCA1 or BLM (grey), Rad50 (green) an...
<p>(<b>A</b>) MG63 and (<b>B</b>) U2OS cells were synchronized by double thymidine block. Asynchrono...
<p>U2OS cells were synchronized by double thymidine block in G1-, S- and G2-stages of the cell cycle...
<p><b>A</b>. Nuclear extracts were immunoprecipitated with antibodies to BRCA1 and the immunoprecipi...
<p>(<b>A</b>) Quantitation of percent of cells with BLM-BRCA1, BRCA1-telomere, and BLM-BRCA1-telomer...
<p>ALT cell lines VA-13, Saos-2, and U-2 OS were transfected with <i>WRN</i>, <i>BRCA1</i>, or <i>WR...
<p>BRCA1 and telomere co-localizations in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>(<b>A</b>) Cells were synchronized to G2 (7h post release after double thymidine block) and stain...
<p>CD18 treated with GRN163L (GRN) or with no drug (CTR) were harvested at the end of the growth cur...
<p>F9, F9A353V and F9A353V cells transfected with GSE24.2 (F9A353V 24.2) (F9 cells were treated with...
<p>X-DC-1787-C and X-DC-1774-P cells untreated (-Bleo) or treated (+Bleo) with bleomycin (10 µg/ml) ...
<p>U2OS cells were synchronized by double thymidine block in G1-, S- and G2-stages of the cell cycle...
<p>SK-N-MC cells were exposed to cisplatinum or doxorubicin for 1 hour and then resuspended in drug ...
<p>(<b>A</b>) Immunostaining-FISH images of WT.1 cells showing co-localization between telomerase RN...
<p>(A) Graph evidence the relative TRT activity of DPSCs cultured in 1.25% HS medium, 10% FBS and 1....
<p>U2OS cells were synchronized and stained with antibodies to BRCA1 or BLM (grey), Rad50 (green) an...
<p>(<b>A</b>) MG63 and (<b>B</b>) U2OS cells were synchronized by double thymidine block. Asynchrono...
<p>U2OS cells were synchronized by double thymidine block in G1-, S- and G2-stages of the cell cycle...
<p><b>A</b>. Nuclear extracts were immunoprecipitated with antibodies to BRCA1 and the immunoprecipi...
<p>(<b>A</b>) Quantitation of percent of cells with BLM-BRCA1, BRCA1-telomere, and BLM-BRCA1-telomer...
<p>ALT cell lines VA-13, Saos-2, and U-2 OS were transfected with <i>WRN</i>, <i>BRCA1</i>, or <i>WR...
<p>BRCA1 and telomere co-localizations in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>(<b>A</b>) Cells were synchronized to G2 (7h post release after double thymidine block) and stain...
<p>CD18 treated with GRN163L (GRN) or with no drug (CTR) were harvested at the end of the growth cur...
<p>F9, F9A353V and F9A353V cells transfected with GSE24.2 (F9A353V 24.2) (F9 cells were treated with...
<p>X-DC-1787-C and X-DC-1774-P cells untreated (-Bleo) or treated (+Bleo) with bleomycin (10 µg/ml) ...
<p>U2OS cells were synchronized by double thymidine block in G1-, S- and G2-stages of the cell cycle...
<p>SK-N-MC cells were exposed to cisplatinum or doxorubicin for 1 hour and then resuspended in drug ...
<p>(<b>A</b>) Immunostaining-FISH images of WT.1 cells showing co-localization between telomerase RN...
<p>(A) Graph evidence the relative TRT activity of DPSCs cultured in 1.25% HS medium, 10% FBS and 1....